CLINICAL_TRIALS
trial_result
· 2022-01-11
Clinical Trial Update: Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy [Phase 4]
Summary
A Phase 4 clinical trial evaluating a probiotic in adult patients with drug-resistant epilepsy has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mazandaran University of Medical Sciences | Conditions: Epilepsy, Treatment | Phase 4 | Status: COMPLETED